Target Audience:

The joint-providership will target an audience consisting of gastroenterologists, nurse practitioners (NPs), physician assistants (PAs), and nurses.

Goal:

The series will focus on emerging treatment updates and review current treatment guidelines.

Educational Objectives:

Upon completion of this educational activity, participants should be able to:

  • Apply real-world and clinical trial data to the care of patients with IBD in clinical practice
  • Describe how comparative effectiveness data from real-world experience and clinical trials can be used to inform clinical decision making in IBD
  • Design evidence-based treatment plans for patients with IBD based on their specific disease characteristics and preferences
  • Summarize implications of the current coronavirus pandemic on the management of patients with IBD

Accreditation Statement:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Purdue University College of Pharmacy and IBD ReMEdY. Purdue University College of Pharmacy, an equal access/equal opportunity institution, is accredited by the ACCME to provide continuing medical education for physicians.

Purdue University College of Pharmacy designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Statement:

All faculty, staff and reviewers involved in the planning, review or presentation of continuing education activities provided by Purdue University College of Pharmacy are required to disclose to the audience any relevant commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity.

All additional planning committee members, staff and reviewers of IBD ReMEdY and Purdue University College of Pharmacy have no relationships to disclose.

Americans with Disabilities Act:

The event staff will be glad to assist you with any special needs (i.e., physical, dietary). Please contact us prior to the event at 1-888-565-5321.

This program is supported by educational grants from AbbVie, Bristol-Myers Squibb, Janssen Biotech, Inc., and Takeda Pharmaceuticals U.S.A., Inc.

Accredited by

Endorsed by:

Provided by:

Virtual Broadcasts
Please enter your Email.
Speaker Date Time Location
Bincy Abraham, MD
Dana Lukin, MD, PhD
Tuesday 01/26/2021 6:00 PM CST Virtual Meeting
Sara Horst, MD, MPH
Lisa Malter, MD, FACG
Thursday 01/28/2021 6:00 PM CST Virtual Meeting
Jami Kinnucan, MD
Arun Swaminath, MD
Tuesday 02/02/2021 6:00 PM EST Virtual Meeting
Christina Ha, MD
Garrett Lawlor, MD
Tuesday 02/02/2021 6:00 PM PST Virtual Meeting
Miguel Regueiro, MD
David Hudesman, MD
Tuesday 02/09/2021 7:00 PM EST Virtual Meeting
Michael Chiorean, MD, AGAF, FASGE, FACG
Dana Lukin, MD, PhD
Thursday 02/11/2021 6:00 PM PST Virtual Meeting
Samir Shah, MD, FACG, FASGE, AGAF
Arun Swaminath, MD
Thursday 02/18/2021 7:00 PM EST Virtual Meeting
Edward Barnes, MD, MPH
Arun Swaminath, MD
Monday 02/22/2021 7:00 PM EST Virtual Meeting
Francis Farraye, MD, MSc
Dana Lukin, MD, PhD
Tuesday 03/09/2021 7:00 PM EST Virtual Meeting
David Rubin, MD
Dana Lukin, MD, PhD
Tuesday 03/16/2021 7:00 PM CDT Virtual Meeting
Stephen Hanauer , MD
Garrett Lawlor, MD
Friday 03/19/2021 5:00 PM CDT Virtual Meeting